WuXi STA’s William Fang, Vice President and Head of New Modalities Oligo & Peptide, discussed trends in oligonucleotide drug development in this virtual panel discussion published in the magazine Chemistry Today.
WuXi STA’s William Fang, Vice President and Head of New Modalities Oligo & Peptide, discussed trends in oligonucleotide drug development in this virtual panel discussion published in the magazine Chemistry Today.